About Us

We're Redefining Early Child Health

Leobery Pharmaceutical industries LLC is a leading multinational pharmaceutical company having presence in more than 60 countries. We are committed to improving global health through innovative medicines, vaccines, and healthcare solutions. With operations in over 60 countries, we strive to make high-quality and affordable treatments accessible to all.

Our R&D Mission

To accelerate scientific innovation that meets unmet medical needs through safe, effective, and accessible pharmaceutical solutions.

Collaborative Innovation

  • We believe that partnerships accelerate progress. Leobery collaborates with:
  • Global academic and clinical research institutions
  • Contract Research Organizations (CROs)
  • Biotech startups and technology innovators

Pipeline & Progress

  • Our expanding pipeline includes:
  • Generic drug launches in regulated and emerging markets
  • New chemical entity (NCE) research in select therapeutic segments
  • Lifecycle management of existing molecules through novel combinations and delivery systems

Quality & Compliance

  • All R&D activities adhere to ICH-GCP, GLP, and local regulatory norms, ensuring scientific rigor, ethical compliance, and patient safety.
  • CNS Disorders – Neurological and psychiatric treatment innovation
  • Pediatrics & Geriatrics – Age-specific drug development and formulations

Capabilities & Strengths

  • Formulation Development – Immediate release, sustained release, and novel drug delivery systems
  • Bioequivalence Studies – In-house or partnered centers for clinical trials and data analysis
  • Regulatory Submissions – Expertise in ANDA, CTD/eCTD formats for global markets
  • Technology Platforms – Use of nanotechnology, liposomal drug delivery, and sustained-release mechanisms

Quality & Compliance

  • All R&D activities adhere to ICH-GCP, GLP, and local regulatory norms, ensuring scientific rigor, ethical compliance, and patient safety.
  • CNS Disorders – Neurological and psychiatric treatment innovation
  • Pediatrics & Geriatrics – Age-specific drug development and formulations